ERBB2 and breast cancer: The percentage of TN and HER2 subtype disease was relatively higher in patients with LMBC than in the entire breast cancer population (approximately 10% vs. 4%)2, suggesting an inclination of lung metastasis related to molecular subtype in patients with LMBC.